Phase II study of bay 43-9006 (SORAFENIB) in patients with chemo-naive hormone refractory prostate cancer (HRPC) Conferences uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Chi, Kim N
  • Ellard, Susan
  • Hotte, Sebastien
  • Czaykowski, Piotr
  • Moore, Malcolm
  • Ruether, Joseph Dean
  • Hansen, Clive
  • Seymour, Lesley

publication date

  • January 1, 2006